Related references
Note: Only part of the references are listed.Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
Jie Liang et al.
CANCER CELL (2013)
STAT5 Outcompetes STAT3 To Regulate the Expression of the Oncogenic Transcriptional Modulator BCL6
Sarah R. Walker et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
Hazel Tye et al.
CANCER CELL (2012)
Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma
Jinming Yang et al.
CANCER RESEARCH (2012)
Roles for MicroRNAs in Conferring Robustness to Biological Processes
Margaret S. Ebert et al.
CELL (2012)
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
Apostolos Kontzias et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer
Ziad Kanaan et al.
HUMAN MUTATION (2012)
Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition
Hua Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Pasquale Sansone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis
Matjaz Rokavec et al.
MOLECULAR CELL (2012)
MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis
Zhibo Hou et al.
MEDICAL ONCOLOGY (2012)
MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer
Bin Xu et al.
PROSTATE (2012)
miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3
Li-hong Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17
Bingbing Dai et al.
CANCER RESEARCH (2011)
An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
Maria Hatziapostolou et al.
CELL (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression
Miaomiao Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
PDGF induced microRNA alterations in cancer cells
Minghai Shao et al.
NUCLEIC ACIDS RESEARCH (2011)
MiR-146b-5p Suppresses EGFR Expression and Reduces In Vitro Migration and Invasion of Glioma
Mark Katakowski et al.
CANCER INVESTIGATION (2010)
The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
Manran Liu et al.
CANCER RESEARCH (2010)
miR-146a Suppresses Invasion of Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
Sarah R. Walker et al.
MOLECULAR PHARMACOLOGY (2010)
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs
Hongping Xia et al.
BRAIN RESEARCH (2009)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis
Douglas R. Hurst et al.
CANCER RESEARCH (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway
Matthias Brock et al.
CIRCULATION RESEARCH (2009)
Hyperactivated NF-κB and AP-1 Transcription Factors Promote Highly Accessible Chromatin and Constitutive Transcription across the Interleukin-6 Gene Promoter in Metastatic Breast Cancer Cells
Matladi N. Ndlovu et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Reciprocal Effects of STAT5 and STAT3 in Breast Cancer
Sarah R. Walker et al.
MOLECULAR CANCER RESEARCH (2009)
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
Erik A. Nelson et al.
BLOOD (2008)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells
D. Bhaumik et al.
ONCOGENE (2008)
Loss of mir-146a function in hormone-refractory prostate cancer
Shi-Lung Lin et al.
RNA (2008)
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of akt and stat5a/b pathways
Lynn M. Neilson et al.
MOLECULAR ENDOCRINOLOGY (2007)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
STAT3 as a central mediator of neoplastic cellular transformation
David A. Frank
CANCER LETTERS (2007)
STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas
S. R. Walker et al.
ONCOGENE (2007)
Interleukin 6, a nuclear factor-κB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-κB inhibition by PS-1145 enhances docetaxel antitumor activity
Josep Domingo-Domenech et al.
CLINICAL CANCER RESEARCH (2006)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The role of IL-6 and STAT3 in inflammation and cancer
DR Hodge et al.
EUROPEAN JOURNAL OF CANCER (2005)
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
TE Battle et al.
BLOOD (2005)
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors
JV Alvarez et al.
CANCER RESEARCH (2005)
Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C
TN Dechow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Co-operative functions between nuclear factors NFκB and CCAT/enhancer-binding protein-β (C/EBP-β) regulate the IL-6 promoter in autocrine human prostate cancer cells
WH Xiao et al.
PROSTATE (2004)
STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1
TE Battle et al.
BLOOD (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype
OY Hong et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
